Table 3.
Comparison of MACE results between the two groups during 12-month follow-up [cases (%)].
| MACE results | Control group (n = 48) | Treatment group (n = 50) | P-value |
|---|---|---|---|
| Hospitalization MACE | 2 (4.17) | 2 (4.0) | NS |
| Perioperative PCI - related myocardial infarction | 1 (2.08) | 1 (2.0) | NS |
| Blood flow rebuilt again | 1 (2.08) | 1 (2.0) | NS |
| Cardiac death | 0 (0) | 0 (0) | - |
| 30d of follow-up MACE | 4 (8.3) | 2 (4.0) | NS |
| Reoccurrence of myocardial infarction | 2 (4.17) | 2 (4.0) | NS |
| Blood flow rebuilt again | 2 (4.17) | 1 (2.0) | NS |
| Cardiac death | 0 (0) | 0 (0) | - |
| 6 months of follow-up MACE | 8 (16.7) | 7 (14.0) | NS |
| Reoccurrence of myocardial infarction | 3 (6.25) | 3 (6.0) | NS |
| Blood flow rebuilt again | 3 (6.25) | 3 (6.0) | NS |
| Cardiac death | 2 (4.17) | 1 (2.0) | NS |
| 12 months of follow-up MACE | 20 (41.7) | 11 (22.0) | 0.046 |
| Reoccurrence of myocardial infarction | 13 (27.1) | 5 (10.0) | 0.047 |
| Blood flow rebuilt again | 4 (8.3) | 4 (8.0) | NS |
| Cardiac death | 3 (6.25) | 2 (4.0) | NS |
MACE, Major adverse cardiovascular events.